about
sameAs
The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitorNorstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-MetOlive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsAraguspongine C induces autophagic death in breast cancer cells through suppression of c-Met and HER2 receptor tyrosine kinase signaling.Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier modelThe indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasionIsothiocyanatostilbenes as novel c-Met inhibitors.Acylated Iridoids and Rhamnopyranoses from Premna odorata (Lamiaceae) as Novel Mesenchymal-Epithelial Transition Factor Receptor Inhibitors for the Control of Breast Cancer.The tobacco cembranoid (1S,2E,4S,7E,11E)-2,7,11-cembratriene-4,6-diol as a novel angiogenesis inhibitory lead for the control of breast malignancies.The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment.The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.(1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancerMarine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity
P50
Q28821187-E9214267-F021-49BB-8764-821CA8ADB5F6Q28828215-33099B7F-9BAD-4245-8708-33AAD54169DEQ33645135-219C4EA8-003C-4E9F-91CD-E9DF8E99DDEAQ33645135-CD23D159-01E5-4ECD-9E6C-6B05008935D7Q35015343-58FDAE6F-032A-44D5-804A-B887BF2211DFQ36301505-B4F0C2D8-B4A1-4725-BD18-BD4BB5620F30Q36437161-97C8C04B-6167-461F-A3C6-9C33B0E8168DQ36562316-8BD86B2D-1633-4D66-9B67-B85E2CB269C8Q38642364-1659BDBB-B837-4747-B222-F7FE608C3399Q38674491-B51B6504-77DD-4045-ABA1-781673F08F17Q38699970-A9F2FC00-2BD0-48B5-A047-DC9DF563D4F0Q38726762-E35E915B-F7D3-4787-9F1D-972F92924C6EQ38737669-CC4D6EC7-020B-44DD-A83F-0CD49B89A578Q38858554-D7C35C43-3304-4031-BC2E-BAF92879DEAEQ38985150-025C7726-8819-4773-8E32-8D3A394EBCB4Q64064879-BB33EF37-E74E-46EB-B1C6-144D1B738571
P50
description
researcher ORCID ID = 0000-0001-9052-7620
@en
wetenschapper
@nl
name
Mohamed M Mohyeldin
@ast
Mohamed M Mohyeldin
@en
Mohamed M Mohyeldin
@es
Mohamed M Mohyeldin
@nl
type
label
Mohamed M Mohyeldin
@ast
Mohamed M Mohyeldin
@en
Mohamed M Mohyeldin
@es
Mohamed M Mohyeldin
@nl
prefLabel
Mohamed M Mohyeldin
@ast
Mohamed M Mohyeldin
@en
Mohamed M Mohyeldin
@es
Mohamed M Mohyeldin
@nl
P106
P1153
56178609900
P31
P496
0000-0001-9052-7620